Please login to the form below
Glooko
This page shows the latest Glooko news and features for those working in and with pharma, biotech and healthcare.
Novo Nordisk to launch connected insulin pens
Responding to this, Novo Nordisk has also signed new partnership agreements with leading players in digital diabetes tech: Dexcom, Glooko and Roche. ... We are pleased to extend our collaboration with Novo Nordisk," said Russ Johannesson, CEO at Glooko.
Latest news
-
Lilly boosts its forthcoming diabetes digital health offering
FDA. approval or clearance. Meanwhile, Lilly’s diabetes rivals Novo Nordisk and Roche both increased their digital health investments this year, partnering with remote monitoring software firm Glooko and acquiring
-
Novo launches personalised diabetes management mobile app
Novo Nordisk’s digital health deal with Glooko has yielded a new diabetes management app that the partners hope will enable users to better manage the condition. ... That was the catalyst to our partnership with Glooko as well as IBM Watson Health and
-
Novo signs personalised digital health deal in diabetes
Will work with Glooko on jointly-developed and branded solutions. Novo Nordisk is set to develop a new range of digital health tools for people with diabetes. ... The Danish firm will collaborate with California's Glooko, which provides remote monitoring
-
Digital disruption
We are seeing a growing number of examples of the latter; these include ECG Check and AliverCor for CVD patients and iBGStar and Glooko, all of which have received FDA approval
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
Novo Nordisk/Glooko. Non-exclusive collaboration to deliver jointly-developed and branded digital health solutions for people with diabetes.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- Sanofi halts recruitment for trials assessing MS treatment
- Eli Lilly to make bebtelovimab commercially available to US states from August
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Powering Rapid Cognitive Analysis with AI
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris
- EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
